Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Nov 30, 2022
Wednesday Nov 30, 2022
touchCONGRESS for touchONCOLOGY
Listen to three experts explore the latest data from the ESGO European Congress on Gynaecological Oncology 2022 on the use of PARP inhibitors in first-line maintenance therapy for advanced ovarian cancer.
The experts
- Prof. Jonathan Ledermann, UCL Cancer Institute, London, UK
- Dr David Tan, National University Cancer Institute, Singapore
- Dr Anna Tinker, BC Cancer, Vancouver, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from GlaxoSmithKline. This medical education is provided by touchIME.
For further information, visit our website:
https://touchoncology.com/education/parp-inhibitors-maintenance-esgo2022/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.